Torrent Pharmaceuticals Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Samir Mehta
Amministratore delegato
₹260.0m
Compenso totale
| Percentuale dello stipendio del CEO | 0.02% |
| Mandato del CEO | 35.8yrs |
| Proprietà del CEO | 0.0002% |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 2.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹18b |
| Jun 30 2024 | n/a | n/a | ₹17b |
| Mar 31 2024 | ₹260m | ₹40k | ₹17b |
| Dec 31 2023 | n/a | n/a | ₹15b |
| Sep 30 2023 | n/a | n/a | ₹13b |
| Jun 30 2023 | n/a | n/a | ₹13b |
| Mar 31 2023 | ₹230m | ₹40k | ₹12b |
| Dec 31 2022 | n/a | n/a | ₹8b |
| Sep 30 2022 | n/a | n/a | ₹8b |
| Jun 30 2022 | n/a | n/a | ₹8b |
| Mar 31 2022 | ₹200m | ₹40k | ₹8b |
| Dec 31 2021 | n/a | n/a | ₹12b |
| Sep 30 2021 | n/a | n/a | ₹13b |
| Jun 30 2021 | n/a | n/a | ₹13b |
| Mar 31 2021 | ₹200m | ₹40k | ₹13b |
| Dec 31 2020 | n/a | n/a | ₹12b |
| Sep 30 2020 | n/a | n/a | ₹12b |
| Jun 30 2020 | n/a | n/a | ₹11b |
| Mar 31 2020 | ₹200m | ₹40k | ₹10b |
| Dec 31 2019 | n/a | n/a | ₹6b |
| Sep 30 2019 | n/a | n/a | ₹6b |
| Jun 30 2019 | n/a | n/a | ₹5b |
| Mar 31 2019 | ₹150m | ₹40k | ₹4b |
| Dec 31 2018 | n/a | n/a | ₹8b |
| Sep 30 2018 | n/a | n/a | ₹6b |
| Jun 30 2018 | n/a | n/a | ₹7b |
| Mar 31 2018 | ₹150m | ₹40k | ₹7b |
Compensazione vs Mercato: La retribuzione totale di Samir ($USD 3.08M ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 1.08M ).
Compensazione vs guadagni: La retribuzione di Samir è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Samir Mehta (60 yo)
35.8yrs
Mandato
₹260,040,000
Compensazione
Mr. Samir Uttamlal Mehta, B.Com., MBA serves as a Managing Director of Torrent Pharmaceuticals Limited since 1989. Mr. Mehta served as Managing Director of Torrent Power Limited. Mr. Mehta has been associa...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman & MD | no data | ₹260.04m | 0.00024% ₹ 2.6m | |
| Whole-Time Director | 2.3yrs | ₹65.88m | 0.000060% ₹ 650.6k | |
| Chief Financial Officer | 6.2yrs | ₹16.30m | Nessun dato | |
| Company Secretary & Compliance Officer | 2.3yrs | Nessun dato | Nessun dato | |
| Vice President of Human Resource | no data | ₹6.56m | Nessun dato | |
| Executive Director | less than a year | ₹8.25m | Nessun dato | |
| Chief Customer Service Officer | 3.4yrs | Nessun dato | Nessun dato | |
| President and CEO of Torrent Pharma USA | no data | Nessun dato | Nessun dato |
2.3yrs
Durata media
58yo
Età media
Gestione esperta: Il team dirigenziale di TORNTPHARM è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman & MD | 35.8yrs | ₹260.04m | 0.00024% ₹ 2.6m | |
| Whole-Time Director | 2.3yrs | ₹65.88m | 0.000060% ₹ 650.6k | |
| Executive Director | less than a year | ₹8.25m | Nessun dato | |
| Chairman Emeritus | 10.3yrs | Nessun dato | 0.00030% ₹ 3.3m | |
| Independent Director | 1.1yrs | ₹2.60m | Nessun dato | |
| Independent Director | 2.3yrs | ₹4.30m | Nessun dato | |
| Independent Director | 6.3yrs | ₹4.90m | 0.00050% ₹ 5.4m | |
| Independent Director | 5.7yrs | ₹6.70m | Nessun dato | |
| Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 2.5yrs | ₹6.30m | Nessun dato |
2.4yrs
Durata media
58yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di TORNTPHARM non è considerato esperto (durata media del mandato 2.4 anni), il che suggerisce un nuovo consiglio.